FR2933984B1 - D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses - Google Patents

D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses

Info

Publication number
FR2933984B1
FR2933984B1 FR0804017A FR0804017A FR2933984B1 FR 2933984 B1 FR2933984 B1 FR 2933984B1 FR 0804017 A FR0804017 A FR 0804017A FR 0804017 A FR0804017 A FR 0804017A FR 2933984 B1 FR2933984 B1 FR 2933984B1
Authority
FR
France
Prior art keywords
atheromous
muramyldipeptide
plaques
treatment
derivative compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0804017A
Other languages
English (en)
Other versions
FR2933984A1 (fr
Inventor
Matthieu Pesant
Jean Louis Connat
Luc Rochette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Bourgogne
Original Assignee
Universite de Bourgogne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Bourgogne filed Critical Universite de Bourgogne
Priority to FR0804017A priority Critical patent/FR2933984B1/fr
Priority to PCT/FR2009/000863 priority patent/WO2010007250A1/fr
Publication of FR2933984A1 publication Critical patent/FR2933984A1/fr
Application granted granted Critical
Publication of FR2933984B1 publication Critical patent/FR2933984B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR0804017A 2008-07-15 2008-07-15 D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses Expired - Fee Related FR2933984B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0804017A FR2933984B1 (fr) 2008-07-15 2008-07-15 D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses
PCT/FR2009/000863 WO2010007250A1 (fr) 2008-07-15 2009-07-13 D, d muramyldipeptides, composes derives et utilisation pour le traitement des plaques atheromaieuses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804017A FR2933984B1 (fr) 2008-07-15 2008-07-15 D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses

Publications (2)

Publication Number Publication Date
FR2933984A1 FR2933984A1 (fr) 2010-01-22
FR2933984B1 true FR2933984B1 (fr) 2013-01-04

Family

ID=40380727

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0804017A Expired - Fee Related FR2933984B1 (fr) 2008-07-15 2008-07-15 D,d muramyldipeptide,composes derives et utilisation pour le traitement des plaques atheromateuses

Country Status (2)

Country Link
FR (1) FR2933984B1 (fr)
WO (1) WO2010007250A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4482849A4 (fr) * 2022-02-25 2026-02-25 Council Scient Ind Res Dipeptides de muramyle et leur procédé de préparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2862107D1 (en) * 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
GR78246B (fr) * 1981-01-23 1984-09-26 Ciba Geigy Ag
GB9413935D0 (en) * 1994-07-11 1994-08-31 Peptech Uk Ltd Use of maramyl peptide compounds
EP1038532A4 (fr) * 1997-04-11 2003-08-13 Oleg Vitallievich Kaljuzhin Regulateur immunologique, composition pharmaceutique possedant une activite antitumorale et additif alimentaire

Also Published As

Publication number Publication date
WO2010007250A1 (fr) 2010-01-21
FR2933984A1 (fr) 2010-01-22

Similar Documents

Publication Publication Date Title
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
FR2932478B1 (fr) Composes utiles pour le traitement des cancers.
HUE061548T2 (hu) Komplementtel összefüggõ rendellenességek kezelésére szolgáló eljárások és készítmények
IL208549A (en) Auris formulations for treating otic diseases and conditions
IL213070A0 (en) Methods for the treatment of infections and tumors
PL2504005T3 (pl) Zastosowanie pochodnych 1,3-difenyloprop-2-en-1-onu do leczenia zaburzeń wątroby
BRPI0917575A2 (pt) métodos de tratamento de talassemia
EP2542255A4 (fr) Méthodes et compositions pour le traitement de la maladie de degos
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
FR2948016B1 (fr) Orthese pour le traitement de la rhizarthrose
PL3476371T3 (pl) Urządzenie do leczenia gerd
LT2464362T (lt) Probiotikų preparatas, skirtas šunų virškinamojo trakto sutrikimų prevencijai arba gydymui
EP2510917A4 (fr) Agent nettoyant pour la peau
EP2249789A4 (fr) Compositions et méthodes pour le traitement de la xérostomie
IL209336B (en) Compositions for treating hyperproliferative diseases and uses thereof
FI20085693A0 (fi) Biosignaalin prosessointi
FR2920671B1 (fr) Implant textile, notamment pour la refection des hernies
EP2583691A4 (fr) Agent pour le traitement de la fibrose rénale
EP2442832A4 (fr) Compositions et procédés pour le traitement de la sclérose en plaques
EP2498792A4 (fr) Procédés et compositions pour le traitement rapide d'une otite externe
EP2389180A4 (fr) Procédés pour le traitement de dystrophies musculaires
EP2536436A4 (fr) Antimir-451 pour le traitement de polycythémies
IL207247A0 (en) Use of ranolazine for the treatment of cardiovascular disease
HRP20160577T1 (hr) Liječenje osteoartritisa

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160331